EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeitOpen Access

Immunotherapeutic effect of MIP vaccine along with multidrug therapy (MDT) in leprosy: A systematic review and meta-analysis

Madhumathi Jayaprakasam, Jigisha Chaudhary, Deenadayalan Boopalan, Rizwan Suliankatchi Abdulkader, Nivedita Gupta

The Indian Journal of Medical Research · 24.08.2026 · 164 · 365-376

DOI: 10.25259/ijmr_538_2026 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 24.08.2026. Verfasst von Madhumathi Jayaprakasam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Communicable Diseases, Indian Council of Medical Research, New Delhi, India. Hauptthemen laut MEDLINE: Leprosy, Immunotherapy, Bacterial Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Leprosy is a neglected tropical disease caused by Mycobacterium leprae often resulting in nerve damage, numbness, disfiguring lesions, and disability. India accounts for ∼52% of the world’s new leprosy patients. Immunotherapy has been reported to achieve faster bacterial clearance in multi-bacillary (MB) leprosy patients. We conducted this systematic review to synthesise the global evidence available for the efficacy and safety of the MIP vaccine ( Mycobacterium indicus pranii ), previously known as Mw, as an immunotherapeutic agent along with standard chemotherapy, on the treatment outcomes in patients with multi-bacillary (MB) and pauci-bacillary (PB) leprosy.

Methods

Three bibliographic databases namely, PubMed, Embase, and Cochrane Library were used for search of articles apart from four clinical trial registries, Google Scholar, and the Google search engine. Articles published between 1980 to 2023 reporting the efficacy of the MIP vaccine for immunotherapy along with standard chemotherapy in leprosy patients were included. Methodological bias was assessed using the RoB2 and ROBIN-I tool. Meta-analysis was carried out from four RCTs and three non-RCTs for the outcomes clinical score and bacterial index following 12 and 24 mo of treatment using the Review Manager 5.4.1 (RevMan).

Results

The pooled analysis of four RCTs with 12 and 24 mo of follow up showed a significant reduction in clinical scores with mean difference of –1.35 [95% confidence interval (CI): –2.12 to –0.57] and –2.62 (95% CI: –4.28 to –0.96) respectively, while the analysis of three non-RCTs showed a mean difference of –2.97 (95% CI: –4.00 to –1.94) and –3.10 (95% CI: –3.84 to –2.37) at 12 and 24 mo respectively. Subgroup analysis showed a significant reduction in clinical scores and bacterial index among borderline lepromatous (BL) and lepromatous leprosy (LL) types of leprosy. The vaccine was reported to be safe and well-tolerated. Interpretation and conclusions This systematic review and meta-analysis confirms the clinical efficacy of the MIP as an immunotherapeutic vaccine in leprosy patients for rapid bacterial clearance and overall clinical improvement when used as an adjunct to chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeprosyImmunotherapyBacterial VaccinesHumansMycobacterium lepraeIndiaDrug Therapy, CombinationLeprostatic Agents

Stichwörter der Autor:innen

Bacterial clearanceClinical improvementEfficacyImmunotherapyLeprosyMIP vaccine

Substanzen

Bacterial VaccinesLeprostatic Agents

Autor:innen und Institutionen

  • Division of Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
  • Department of Yoga and Naturopathy, Central Council for Research in Yoga and Naturopathy (CCRYN), Ministry of Ayush, New Delhi, India.
  • Department of ICMR School of Public Health, ICMR-National Institute of Epidemiology, Chennai, Tamil Nadu, India.

Zitieren

APA

Jayaprakasam, M., Chaudhary, J., Boopalan, D., Abdulkader, R. S., & Gupta, N. (2026). Immunotherapeutic effect of MIP vaccine along with multidrug therapy (MDT) in leprosy: A systematic review and meta-analysis. The Indian Journal of Medical Research, 164, 365-376. https://doi.org/10.25259/ijmr_538_2026

Vancouver

Jayaprakasam M, Chaudhary J, Boopalan D, Abdulkader RS, Gupta N. Immunotherapeutic effect of MIP vaccine along with multidrug therapy (MDT) in leprosy: A systematic review and meta-analysis. The Indian Journal of Medical Research. 2026;164:365-376. doi:10.25259/ijmr_538_2026

BibTeX
@article{Jayaprakasam2026,
  author = {Jayaprakasam, Madhumathi and Chaudhary, Jigisha and Boopalan, Deenadayalan and Abdulkader, Rizwan Suliankatchi and Gupta, Nivedita},
  title = {Immunotherapeutic effect of MIP vaccine along with multidrug therapy (MDT) in leprosy: A systematic review and meta-analysis},
  journal = {The Indian Journal of Medical Research},
  year = {2026},
  volume = {164},
  pages = {365--376},
  doi = {10.25259/ijmr_538_2026}
}
Kostenlos starten →